These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9923885)

  • 1. Lipid-lowering drugs and homocysteine.
    de Lorgeril M; Salen P; Paillard F; Lacan P; Richard G
    Lancet; 1999 Jan; 353(9148):209-10. PubMed ID: 9923885
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia.
    Milionis HJ; Papakostas J; Kakafika A; Chasiotis G; Seferiadis K; Elisaf MS
    J Clin Pharmacol; 2003 Aug; 43(8):825-30. PubMed ID: 12953339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fenofibrate and gemfibrozil on plasma homocysteine.
    Bostom AG
    Lancet; 2001 Nov; 358(9295):1811-2. PubMed ID: 11734262
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitamin supplementation can markedly reduce the homocysteine elevation induced by fenofibrate.
    Dierkes J; Westphal S; Kunstmann S; Banditt P; Lössner A; Luley C
    Atherosclerosis; 2001 Sep; 158(1):161-4. PubMed ID: 11500187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease.
    Farnier M; Retterstøl K; Steinmetz A; Császár A
    Diab Vasc Dis Res; 2012 Jul; 9(3):205-15. PubMed ID: 22228773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fibrates: mechanism of action, effect on levels of lipids and risk of coronary events. II. Fenofibrate].
    Dobordzhginidze LM
    Kardiologiia; 2004; 44(3):87-93. PubMed ID: 15489838
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrates and homocysteine.
    Young IS; Woodside JV
    Nutrition; 2001; 17(11-12):973-4. PubMed ID: 11744353
    [No Abstract]   [Full Text] [Related]  

  • 8. Correction to the FIELD study report.
    Keech A; Simes J; Barter P; Best J; Scott R; Taskinen MR;
    Lancet; 2006 Oct; 368(9545):1415. PubMed ID: 17055933
    [No Abstract]   [Full Text] [Related]  

  • 9. The I allele of the angiotensin-converting enzyme gene polymorphism may determine an increase in homocysteine levels in fibrate-treated subjects.
    Potaczek DP; Undas A; Celinska-Lowenhoff M; Szczeklik A
    Cardiovasc Drugs Ther; 2006 Jun; 20(3):229-32. PubMed ID: 16779534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixed-dose combination fenofibrate/pravastatin 160/40 mg versus simvastatin 20 mg monotherapy in adults with type 2 diabetes and mixed hyperlipidemia uncontrolled with simvastatin 20 mg: a double-blind, randomized comparative study.
    Farnier M; Steinmetz A; Retterstøl K; Császár A
    Clin Ther; 2011 Jan; 33(1):1-12. PubMed ID: 21397769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niacin, fenofibrates increase benefits for statin users. These HDL- raising, triglyceride-lowering drugs beat out the use of additional LDL-lowering drugs.
    Duke Med Health News; 2010 Aug; 16(8):1-2. PubMed ID: 20799416
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels.
    Dierkes J; Westphal S; Luley C
    Expert Opin Drug Saf; 2004 Mar; 3(2):101-11. PubMed ID: 15006716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of fenofibrate and gemfibrozil on plasma homocysteine.
    Chan NN; Chow FC
    Lancet; 2001 Nov; 358(9295):1811; author reply 1811-2. PubMed ID: 11734263
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and efficacy of simvastatin for hyperlipidemia in renal transplant recipients: a double-blind, randomized, placebo-controlled study.
    Santos AF; Keitel E; Bittar AE; Neumann J; Fuchs FD; Goldani JC; Fonseca NA; Prates VC; Zaffan D; Voegeli C; Kroth L; Steffenello G; Saitovitch D; Garcia VD
    Transplant Proc; 2001; 33(1-2):1194-5. PubMed ID: 11267254
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fenofibrate].
    Yamashita T; Nakamura H
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():618-24. PubMed ID: 11347142
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum homocysteine increases after therapy with fenofibrate or bezafibrate.
    Dierkes J; Westphal S; Luley C
    Lancet; 1999 Jul; 354(9174):219-20. PubMed ID: 10421307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting and correcting hyperlipidemia.
    Hall RR
    Hosp Pract (1995); 1998 Nov; 33(11):83-90, 95-9; discussion 99-100, 102. PubMed ID: 9826960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of combination therapy with fenofibrate and simvastatin on postprandial lipemia in the ACCORD lipid trial.
    Reyes-Soffer G; Ngai CI; Lovato L; Karmally W; Ramakrishnan R; Holleran S; Ginsberg HN
    Diabetes Care; 2013 Feb; 36(2):422-8. PubMed ID: 23033246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of fibrate therapy for homocysteine.
    Goffin E; Jamar F; Desager JP; Devuyst O
    Lancet; 1999 Oct; 354(9185):1209. PubMed ID: 10513738
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary prevention of ischaemic heart disease with lipid-lowering drugs.
    Lancet; 1988 Feb; 1(8581):333-4. PubMed ID: 2893141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.